Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?

Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?

Glioblastoma multiforme (GB) is the most aggressive and frequent primary malignant tumor in the central nervous system (CNS), with unsatisfactory and challenging treatment nowadays. Current standard of care includes surgical resection followed by chemotherapy and radiotherapy. However, these treatme...

Full description

Bibliographic Details
Main Authors: Daniel Ruiz-Molina, Xiaoman Mao, Paula Alfonso-Triguero, Julia Lorenzo, Jordi Bruna, Victor J. Yuste, Ana Paula Candiota, Fernando Novio
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
glioblastoma
preclinical model
nanoparticles
drug delivery
brain cancer
BBB
Online Access:https://www.mdpi.com/2072-6694/14/19/4960

Internet

https://www.mdpi.com/2072-6694/14/19/4960

Similar Items